Eagle Veterinary Technology Co.Ltd (044960) — Capital Reinvestment Ratio

Latest as of June 2026: 0.04x

Eagle Veterinary Technology Co.Ltd (044960) has a Capital Reinvestment Ratio of 0.04x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩1.50 Billion) in capital expenditures (₩54.18 Million). Check Eagle Veterinary Technology Co.Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.04x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.50 Billion
KRW

Capital Expenditures

₩54.18 Million
KRW

Data as of

Jun 2026
Most recent filing

Eagle Veterinary Technology Co.Ltd Capital Reinvestment Ratio (2014–2025)

This chart tracks Eagle Veterinary Technology Co.Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see 044960 cash generation efficiency.

Annual Capital Reinvestment Ratio for Eagle Veterinary Technology Co.Ltd (2014–2025)

Year-by-year Capital Reinvestment Ratio for Eagle Veterinary Technology Co.Ltd from 2014 to 2025. See cash generation quality of Eagle Veterinary Technology Co.Ltd to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.29x ₩5.51 Billion ₩1.60 Billion ▼ -55.4%
2024 0.65x ₩4.34 Billion ₩2.83 Billion ▼ -31.9%
2023 0.96x ₩4.89 Billion ₩4.69 Billion ▲ +3068.3%
2021 0.03x ₩6.13 Billion ₩185.59 Million ▼ -77.3%
2020 0.13x ₩5.90 Billion ₩784.87 Million ▲ +2.7%
2019 0.13x ₩2.92 Billion ₩378.68 Million ▼ -79.2%
2018 0.62x ₩2.02 Billion ₩1.26 Billion ▼ -82.7%
2017 3.61x ₩511.60 Million ₩1.84 Billion ▲ +1395.4%
2016 0.24x ₩3.13 Billion ₩754.08 Million ▼ -96.7%
2014 7.40x ₩1.87 Billion ₩13.85 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow